Published in Pharmazie on February 26, 1980
Annual night visiting rates in 129 general practices in one family health services authority: association with patient and general practice characteristics. Br J Gen Pract (1995) 1.43
[Alcohol as an agent against coronary heart disease-- flippancy or fact?]. Tidsskr Nor Laegeforen (1997) 1.39
Specific developmental gene silencing in the honey bee using a homeobox motif. Insect Mol Biol (2002) 1.32
Centralization of low back pain and perceived functional outcome. J Orthop Sports Phys Ther (1998) 1.04
Genetic epidemiology of BRCA1 mutations in Norway. Eur J Cancer (2001) 0.92
Secondary post partum haemorrhage due to uterine wound dehiscence. Cent Afr J Med (1995) 0.91
Biomedical and pharmaceutical applications of alginate and chitosan. Biotechnol Genet Eng Rev (1999) 0.91
[Synthesis and analgesic effect of 2-aryliminomethylquinolines]. Pharmazie (1983) 0.88
Cell therapy using encapsulated cells producing endostatin. Acta Neurochir Suppl (2003) 0.85
Polyphosphoinositide metabolism in erythrocytes of spontaneously hypertensive rats. Biochem Pharmacol (1981) 0.83
Substance P: does it produce analgesia or hyperalgesia? Science (1980) 0.83
[Prediction of LD50 values by cell culture]. Pharmazie (1987) 0.81
Epignathus: always a simple teratoma? Report of an exceptional case with two additional fetiforme bodies. Ultrasound Obstet Gynecol (2003) 0.80
Severity of psoriasis and health-related quality of life: the moderating effects of temperament. Br J Dermatol (2007) 0.79
Asherman syndrome caused by schistosomiasis. Obstet Gynecol (1995) 0.79
Influence of inhibitors of the eicosanoid metabolism, of antagonists of the eicosanoids and of PAF on mortality assayed in three biochemically characterized shock models. Biomed Biochim Acta (1988) 0.79
[Contribution to the atypical macroglia in nonhepatic diseases (author's transl)]. Zentralbl Allg Pathol (1978) 0.78
[32P'incorporation into polyphosphoinositides of erythrocytes from essential hypertension]. Acta Biol Med Ger (1981) 0.78
Host risk factors for the development of reactive arthritis: a family study. J Rheumatol (1993) 0.78
[The technique of outflow tract reconstruction in patients with tetralogy of Fallot influence the morbidity 3 decades after repair]. Z Kardiol (2004) 0.78
Responses of normal and rheumatic human articular chondrocytes cultured under various experimental conditions in agarose. Scand J Rheumatol (1991) 0.76
Reproductive outcomes in women exposed to solvents in 36 reinforced plastics companies. I. Menstrual dysfunction. J Occup Med (1985) 0.75
Echocardiographic diagnosis of a cardiac fibrosarcoma in the right atrium of a sheep. Schweiz Arch Tierheilkd (1995) 0.75
[On the composition of fatty acids in Chlorella pyrenoidosa under the influence of dimethyl- and diethylaminoazobenzene (author's transl)]. Arch Geschwulstforsch (1975) 0.75
[Anti-arrhythmic action of some amidinohydrazone substituted benzophenones. 1. Synthesis of new amidinohydrazone and N-phenylamidinohydrazone substituted benzophenones]. Pharmazie (1992) 0.75
[Acute cerebrovascular disease at the internal medicine hospital]. Z Gesamte Inn Med (1987) 0.75
[Neuroradiologic study of patients with spinal injuries]. Z Arztl Fortbild (Jena) (1986) 0.75
[The spinal emergency. Urgent indications for surgical intervention in spondylogenic lumbar processes]. Z Arztl Fortbild (Jena) (1989) 0.75
Substance P--new aspect to its modulatory function. Acta Biol Med Ger (1980) 0.75
[The analgesic action of d-phenylalanine in combination with morphine or methadone]. Pharmazie (1991) 0.75
[Pharmacologic spectrum of guanylhydrazones (proceedings)]. Pharmazie (1980) 0.75
[Potential cardiotonic agents. 4. Synthesis, cardiovascular activity, molecular and crystal structure of 5-phenyl- and 4-(4-pyridinyl)-substituted 2(1H)-pyridinethiones]. Pharmazie (1989) 0.75
[ECG abnormalities in Airedale terriers]. Tierarztl Prax (1996) 0.75
[Ultrasonic tomography--a noninvasive, imaging study method in lumbar canal diagnosis]. Radiol Diagn (Berl) (1988) 0.75
[Effect of morphine on polyphosphoinositides of erythrocytes of spontaneously hypertensive rats]. Acta Biol Med Ger (1982) 0.75
[Potential cardiotonic agents. 6. Synthesis and cardiovascular properties of 5-(4-pyridinyl)-, 6-methyl-5-(4-pyridinyl)- and 6-methyl-5-phenyl-substituted 3-cyano-2-oxaalkyoxy-pyridines]. Pharmazie (1990) 0.75
[Subchronic toxicity testing of Cordemcura in the mini-Lewe minipig]. Pharmazie (1986) 0.75
[Amalgams--discussion of a controversy]. Pharmazie (1994) 0.75
[Potential cardiotonic agents. 10. Synthesis and positive inotropic action of 5-(4-pyridinyl)- and 5-phenyl-substituted 2-alkylthio-3-cyan-pyridines and their S-oxidation products]. Pharmazie (1990) 0.75
[Peroxisome induction with clofibric acid and bis(p-chlorophenoxy)acetic acid (proceedings)]. Pharmazie (1980) 0.75
Patents and literature. Appl Biochem Biotechnol (1981) 0.75
Protection by antiarrhythmic drugs against ischemia-induced arrhythmias occurring during coronary artery occlusion in the rat. Biomed Biochim Acta (1987) 0.75
[Incidence of abnormalities following the use of hormonal contraceptives]. Zentralbl Gynakol (1989) 0.75
[A personal milk bank in the State Hospital]. Jordmorbladet (1997) 0.75
[Potential cardiotonics. 14. Synthesis and in vitro positive inotropic actions of 4-morpholino-5-(4-pyridinyl)pyridine derivatives]. Pharmazie (1992) 0.75
[Lipoxygenase inhibitors and mast cell degranulation]. Biomed Biochim Acta (1988) 0.75
[What is your diagnosis? Pulmonary edema following changes in capillary permeability due to acute respiratory distress syndrome]. Schweiz Arch Tierheilkd (1997) 0.75
[In vitro cultivation of aortic endothelial cells in pharmaceutical research--characterization of cell physiology and possibilities of using the cell line BKEz-7]. Pharmazie (1984) 0.75
The potential for aromatase inhibition in breast cancer prevention. Clin Cancer Res (2001) 0.75
[Study of the load-carrying capacity of female machinists from the gynecologic viewpoint]. Zentralbl Gynakol (1968) 0.75
[Synthesis and alpha-adrenolytic activities of 2-(1,4-benzodioxan-2-yl- methyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives]. Pharmazie (1990) 0.75
[The effect of acetazolamide and some related sulfonamides on urea and glutaminase synthesis. I. Activity in vitro]. Biochem Pharmacol (1965) 0.75
[Modification of smooth muscle contractility by Cordemcura]. Pharmazie (1986) 0.75
[Spinal epidural hematoma and its etiology]. Zentralbl Chir (1991) 0.75
[Immunoregulatory effect of nourseothricin sulfate]. Arch Exp Veterinarmed (1986) 0.75
Experimental evaluation of the spasmogenicity of dopamine on the basilar artery. J Neurosurg (1976) 0.75
[Proliferation inhibition and lipid accumulation in cell cultures with clofibrinic acid (Regadrin)]. Pharmazie (1977) 0.75
Kinetic enzymatic method for automated determination of glucose in blood and serum. J Clin Chem Clin Biochem (1977) 0.75
Inhibition of post-extraction alveolar ridge resorption in rats by dichloromethane diphosphonate. J Periodontal Res (1982) 0.75
[Spasmolytic activity of (3,4-dichloroanilino)phenylacetonitrile (H 74) and its analogs]. Pharmazie (1983) 0.75
Ultrafast dynamics of delocalized and localized electrons in carbon nanotubes. Phys Rev Lett (2006) 0.75
[Potential cardiotonic agents. 11. Synthesis and cardiovascular effects of 5-alkyl-substituted 2-amino-3-cyano-5- -4-dyl)pyridines]. Pharmazie (1990) 0.75
[Prognostic factors and results of treatment in endometrial carcinoma]. Zentralbl Gynakol (1996) 0.75
[On the use of fluorides in the daily dental practice and at home]. Nor Tannlaegeforen Tid (1968) 0.75
[Potential cardiotonic agents. 8. 2-acyloxyalkylamino-, 2-acyloxyalkoxy-, and 2-acylaminoalkylamino-3-cyan-5-(pyrid-4-yl) pyridine]. Pharmazie (1990) 0.75
[Potential cardiotonics. 7. Synthesis and cardiovascular effects of 5-(4-pyridinyl)-, 6-methyl-4-(4-pyridinyl) and 6-methyl-5-phenyl-substituted 3-cyano-2-aminoalkylamino-pyridines]. Pharmazie (1990) 0.75
[Gas chromatographic analysis of unesterified and triglyceride fatty acids in the plasma of albino rats with neurotically induced hypertonic blood pressure dysregulation]. Acta Biol Med Ger (1974) 0.75
[Analgesic effect, tolerance development and dependence potential of D-phenylalanine]. Pharmazie (1985) 0.75
Antihypoxic effects of AWD 23-15 in mice and rats. Biomed Biochim Acta (1989) 0.75
[Micromethod for the determination of phospholipids (author's transl)]. Pharmazie (1979) 0.75
[The comparative action of calcium valproate (Convulsofin) with sodium valproate and free acid]. Pharmazie (1984) 0.75
[Antiarrhythmic amidinohydrazone substituted benzophenones. 2. Preparation and determination of configuration of (Z)- and (E)-2-amino-5-chlorobenzophenone amidinohydrazone salts]. Pharmazie (1992) 0.75
[What is your diagnosis? Congenital pulmonary stenosis with signs of a distinct diminishing lung perfusion]. Schweiz Arch Tierheilkd (1995) 0.75
[Extending informative value of intracranial pressure measurement by cerebral pressure amplitudes (Pa)--analysis of average intracranial pressure (Pm)]. Zentralbl Chir (1992) 0.75
Hydrops fetalis caused by a large intrapericardial teratoma. Ultrasound Obstet Gynecol (2006) 0.75
[Sterile, purulent meningitis and generalized vasculitis caused by a new drug for prevention of nidation in the dog]. Schweiz Arch Tierheilkd (1987) 0.75
[Is the prediction of LD50 using cell cultures generally valid?]. Pharmazie (1987) 0.75
[Potential cardiotonics. 5. Preparation and properties of 6-unsubstituted and 6-methyl-substituted 3-cyan-5-(pyrid-4-yl)pyridine]. Pharmazie (1989) 0.75
Comparison of the action of antiphlogistics, anti-anaphylactics and antihistaminics in the carrageenin- & immunologically-induced inflammation model in the rat and in passive cutaneous anaphylaxis. Agents Actions Suppl (1982) 0.75
[The antianaphylactic effect of derivatives of 4-oxoquinazoline, 4-oxoquinazol-3-yl-benzoic acid and 4-oxoquinazol-3-yl-acetic acid in the rat]. Pharmazie (1984) 0.75
[Potential cardiotonics. 9. Synthesis and cardiovascular effects of 2-(pyrid-3-yl)-methylamino-, 2-(3-amino-pyrazolidino)- and 2-hetarylamino-substituted 3-cyan-5-(pyrid-4-yl)-pyridines]. Pharmazie (1989) 0.75
[Pharmacologic spectrum of deseminopancreozymin octapeptide (proceedings)]. Pharmazie (1980) 0.75
[Acute and subacute toxicity of Cordemcura]. Pharmazie (1986) 0.75
[Cardiac effects of Cordemcura in vitro]. Pharmazie (1986) 0.75
[Ovulen in the treatment of the premenstrual syndromes in psychiatric patients]. Ugeskr Laeger (1967) 0.75
[Potential cardiotonic agents. 1. Synthesis and pharmacologic properties of 3-cyano-2-oxaalkylamino-5-(4-pyridinyl)pyridines]. Pharmazie (1989) 0.75
[What is your diagnosis? Decompensating dilated cardiomyopathy]. Schweiz Arch Tierheilkd (1993) 0.75
[Linear relations of brain pulse amplitude to mean intracranial pressure]. Zentralbl Neurochir (1992) 0.75
[What is your diagnosis? What measures do you recommend?]. Schweiz Arch Tierheilkd (1986) 0.75
Early diagnosis of conjoined twins by real-time three-dimensional ultrasound--case report and review of the literature. Ultraschall Med (2006) 0.75
[Spectrum of the adverse effects of Cordemcura]. Pharmazie (1986) 0.75
[Synthesis and pharmacologic properties of pranolium and its optical isomers]. Pharmazie (1990) 0.75
[Synthesis and spectrum of pharmacologic action of aryl-arylamino- and aryl-aryliminoacetonitriles]. Pharmazie (1983) 0.75
[Potential cardiotonic agents. 2. Synthesis and pharmacologic properties of 5-(pyri-4-yl)- and 5-phenyl substituted 3-cyano-6-methyl-2-oxaalkylaminopyridines]. Pharmazie (1989) 0.75